RetinalGenix Technologies Inc. (RTGN)
OTCMKTS
· Delayed Price · Currency is USD
3.650
-1.370 (-27.29%)
At close: Jun 2, 2025
RetinalGenix Technologies Market Cap
RetinalGenix Technologies has a market cap or net worth of $67.61 million as of July 3, 2025.
Market Cap
67.61M
Enterprise Value
68.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.65
Market Cap Chart
Since February 24, 2022, RetinalGenix Technologies's market cap has increased from 42.85M to 67.61M, an increase of 57.79%. That is a compound annual growth rate of 14.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 2, 2025 | 67.61M | -28.74% |
Dec 24, 2024 | 94.87M | 121.42% |
Feb 24, 2022 | 42.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.63B |
Veradigm | 823.67M |
Nika Pharmaceuticals | 708.22M |
Elite Pharmaceuticals | 640.84M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 540.25M |
American Oncology Network | 443.39M |
Northwest Biotherapeutics | 363.62M |